Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors

Table 3 Clinicopathologic factors of poor prognosis carcinoma in the subgroup analysis of the carcinoma group n (%)

Initial Dx	Total n = 104	Carcinoma group		P value
Final Dx		Non-poor prognostic carcinoma n = 75	Poor prognostic carcinoma n = 29
Sex				0.924
Male	71 (68.3)	51 (68.0)	20 (69.0)
Female	33 (31.7)	24 (32.0)	9 (31.0)
Age (yr)				0.053
< 60	32 (30.8)	19 (25.3)	13 (44.8)
≥ 60	72 (69.2)	56 (74.7)	16 (55.2)
Endoscopic size (mm)				0.082
< 10	35 (33.7)	29 (38.7)	6 (20.7)
≥ 10	69 (66.3)	46 (61.3)	23 (79.3)
Location I				0.162
Upper	9 (8.7)	7 (9.3)	2 (6.9)
Middle	29 (27.9)	17 (22.7)	12 (41.4)
Lower	66 (63.5)	51 (68.0)	15 (51.7)
Gross type				0.034
Elevated (type I and IIa)	45 (43.3)	36 (48.0)	9 (31.0)
Flat (type IIb)	34 (32.7)	26 (34.7)	8 (27.6)
Depressed (type IIc and III)	25 (24.0)	13 (17.3)	12 (41.4)
Color change				0.745
Redness	64 (61.5)	45 (60.0)	19 (65.5)
Whitish	13 (12.5)	9 (12.0)	4 (13.8)
No change	27 (26.0)	21 (28.0)	6 (20.7)
Single lesion				0.186
No	7 (9.3)	7 (6.7)	0 (0)
Yes	97 (93.3)	68 (90.7)	29 (100)
Ulcer				0.010
No	70 (67.3)	56 (74.7)	14 (48.3)
Yes	34 (32.7)	19 (25.3)	15 (51.7)
Spontaneous bleeding				0.517
No	73 (70.2)	54 (72.0)	19 (65.5)
Yes	31 (29.8)	21 (28.0)	10 (34.5)
Fold change				0.001
No	91 (87.5)	71 (94.7)	20 (69.0)
Yes	13 (12.5)	4 (5.3)	9 (31.0)
Initial Bx				0.707
Regenerating atypia	9 (8.7)	6 (8.0)	3 (10.3)
Atypical epithelium	95 (91.3)	69 (92.0)	26 (89.7)
Repeated IFND				1.000
No	92 (88.5)	66 (88.0)	26 (89.7)
Yes	12 (11.5)	9 (12.0)	3 (10.3)

Dx: Diagnosis; IFND: Indefinite for neoplasm/dysplasia; Bx: Biopsy.